SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001354488-14-006114
Filing Date
2014-12-09
Accepted
2014-12-09 16:58:35
Documents
3
Period of Report
2014-10-02
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO CURRENT REPORT tbuff_8ka.htm 8-K/A 38966
2 ASSET PURCHASE AGREEMENT tbuff_ex21.htm EX-2.1 309781
3 LICENSE AGREEMENT tbuff_ex22.htm EX-2.2 162307
  Complete submission text file 0001354488-14-006114.txt   512290
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-31198 | Film No.: 141275661
SIC: 2834 Pharmaceutical Preparations